Futura Medical (LON:FUM) Stock Falls 10.2% – Should You Sell?

Shares of Futura Medical plc (LON:FUM – Get Free Report) dropped 10.2% during trading on Tuesday. The company traded as low as GBX 0.18 and last traded at GBX 0.21. Approximately 15,721,019 shares changed hands during mid-day trading, an increase of 39% from the average daily volume of 11,277,613 shares. The stock had previously closed at GBX 0.24.

Futura Medical Price Performance

The business’s 50 day moving average price is GBX 0.21 and its 200 day moving average price is GBX 0.66. The stock has a market capitalization of £3.14 million, a P/E ratio of -0.26 and a beta of 0.02.

Futura Medical (LON:FUM – Get Free Report) last issued its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. As a group, analysts forecast that Futura Medical plc will post 2.85 earnings per share for the current fiscal year.

About Futura Medical

(Get Free Report)

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products. Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.

Recommended Stories

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.